DELLAVEDOVA, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 216
EU - Europa 118
NA - Nord America 87
SA - Sud America 26
AF - Africa 4
OC - Oceania 1
Totale 452
Nazione #
US - Stati Uniti d'America 86
SG - Singapore 64
CN - Cina 45
VN - Vietnam 41
HK - Hong Kong 40
IT - Italia 31
RU - Federazione Russa 31
BR - Brasile 22
IE - Irlanda 12
DE - Germania 11
KR - Corea 11
IN - India 7
NL - Olanda 7
FI - Finlandia 6
GB - Regno Unito 6
FR - Francia 5
ES - Italia 4
AR - Argentina 2
EG - Egitto 2
TW - Taiwan 2
ZA - Sudafrica 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CA - Canada 1
CH - Svizzera 1
DK - Danimarca 1
EC - Ecuador 1
ID - Indonesia 1
JP - Giappone 1
KW - Kuwait 1
PL - Polonia 1
SE - Svezia 1
TM - Turkmenistan 1
TR - Turchia 1
VE - Venezuela 1
Totale 452
Città #
Hong Kong 40
Singapore 32
Ashburn 21
Hanoi 14
Dublin 11
Hefei 11
Milan 11
Ho Chi Minh City 8
Seoul 8
Los Angeles 7
Frankfurt am Main 5
Beijing 4
Helsinki 4
Shanghai 4
Chicago 3
Dallas 3
Moscow 3
New York 3
Nuremberg 3
Santa Clara 3
Turin 3
Bergamo 2
Boardman 2
Bologna 2
Boston 2
Buffalo 2
Bắc Giang 2
Cairo 2
Cape Town 2
Chengdu 2
Da Nang 2
Elk Grove Village 2
Hyderabad 2
Lappeenranta 2
Manchester 2
Orléans 2
Partinico 2
Perugia 2
Rotterdam 2
San Francisco 2
Santa Cruz 2
Yeonsu-gu 2
Adana 1
Amsterdam 1
Araras 1
Ashgabat 1
Bari 1
Bethesda 1
Botucatu 1
Buriti Bravo 1
Bắc Ninh 1
Bến Lức 1
Cabo de Santo Agostinho 1
Caldas Novas 1
Campinas 1
Campos dos Goytacazes 1
Can Tho 1
Carapicuíba 1
Changsha 1
Charlotte 1
Chongqing 1
Clarksville 1
Council Bluffs 1
Delhi 1
Desio 1
Dhaka 1
Dietikon 1
Dongguan 1
Düsseldorf 1
Frederiksberg 1
Glew 1
Guapiara 1
Hangzhou 1
Jacksonville 1
Jequié 1
João Pessoa 1
João Pinheiro 1
Juiz de Fora 1
Jundiaí 1
Kochi 1
Kuwait City 1
Lages 1
Limeira 1
Macaé 1
Maracaibo 1
Mediglia 1
Melzo 1
Montreal 1
Morrinhos 1
Munich 1
Nam Định 1
Nha Trang 1
Ninh Bình 1
North Bergen 1
Oakland 1
Paris 1
Pekanbaru 1
Peterborough 1
Pindamonhangaba 1
Pontal 1
Totale 301
Nome #
STRATEGIES TO OVERCOME OLAPARIB DRAWBACKS: FROM PATIENT SELECTION TO NOVEL THERAPIES 174
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin 107
The next generation PARP inhibitor AZD5305 is active in a broad range of pre-clinical models of ovarian cancer 93
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases 92
Totale 466
Categoria #
all - tutte 1.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024103 0 0 0 15 5 6 7 36 4 15 7 8
2024/2025194 9 13 5 7 14 6 16 7 15 27 15 60
2025/2026169 40 27 17 36 41 8 0 0 0 0 0 0
Totale 466